Therapeutic Potential of Nanocurcumin in Mitigating Duloxetine‐Induced Hepatic Damage: Biochemical and Histopathological Insights
Nanocurcumin exhibits potent hepatoprotective effects against duloxetine‐induced liver injury, likely through enhancement of antioxidant capacity and modulation of inflammatory responses, and these findings support its potential as an adjunctive therapy to duloxetine to mitigate hepatic side effects.